Sweden
· Delayed Price · Currency is SEK Medclair AB Statistics
Total Valuation
Medclair AB has a market cap or net worth of SEK 102.29 million. The enterprise value is 100.38 million.
| Market Cap | 102.29M |
| Enterprise Value | 100.38M |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Medclair AB has 82.49 million shares outstanding. The number of shares has increased by 9.75% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 82.49M |
| Shares Change (YoY) | +9.75% |
| Shares Change (QoQ) | -10.55% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.48 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 5.80 |
| P/FCF Ratio | 33.09 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -97.84 |
| EV / Sales | 2.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 32.47 |
Financial Position
The company has a current ratio of 2.06
| Current Ratio | 2.06 |
| Quick Ratio | 0.96 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.05 |
Financial Efficiency
Return on equity (ROE) is -2.00% and return on invested capital (ROIC) is -7.58%.
| Return on Equity (ROE) | -2.00% |
| Return on Assets (ROA) | -6.41% |
| Return on Capital (ROIC) | -7.58% |
| Revenue Per Employee | 3.07M |
| Profits Per Employee | -73,286 |
| Employee Count | 14 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.63% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -26.63% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 1.44 |
| Relative Strength Index (RSI) | 42.58 |
| Average Volume (20 Days) | 125,558 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medclair AB had revenue of SEK 42.98 million and -1.03 million in losses. Loss per share was -0.01.
| Revenue | 42.98M |
| Gross Profit | 25.72M |
| Operating Income | -6.25M |
| Pretax Income | -1.02M |
| Net Income | -1.03M |
| EBITDA | -1.75M |
| EBIT | -6.25M |
| Loss Per Share | -0.01 |
Balance Sheet
| Cash & Cash Equivalents | 1.91M |
| Total Debt | n/a |
| Net Cash | 1.91M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 50.66M |
| Book Value Per Share | 0.61 |
| Working Capital | 9.94M |
Cash Flow
In the last 12 months, operating cash flow was 4.12 million and capital expenditures -1.03 million, giving a free cash flow of 3.09 million.
| Operating Cash Flow | 4.12M |
| Capital Expenditures | -1.03M |
| Free Cash Flow | 3.09M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 59.83%, with operating and profit margins of -14.54% and -2.39%.
| Gross Margin | 59.83% |
| Operating Margin | -14.54% |
| Pretax Margin | -2.36% |
| Profit Margin | -2.39% |
| EBITDA Margin | -4.07% |
| EBIT Margin | -14.54% |
| FCF Margin | 7.19% |
Dividends & Yields
Medclair AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.75% |
| Shareholder Yield | -9.75% |
| Earnings Yield | -0.96% |
| FCF Yield | 3.02% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medclair AB has an Altman Z-Score of 8.44.
| Altman Z-Score | 8.44 |
| Piotroski F-Score | n/a |